fluocinolone has been researched along with mifepristone in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Frederick, J; Garabedian, MJ; Wang, Z | 1 |
Ashton, P; Ayalasomayajula, SP; Kompella, UB | 1 |
2 other study(ies) available for fluocinolone and mifepristone
Article | Year |
---|---|
Deciphering the phosphorylation "code" of the glucocorticoid receptor in vivo.
Topics: Amino Acid Sequence; Biomarkers; Cell Compartmentation; Dexamethasone; Fluocinolone Acetonide; Fluorescent Antibody Technique; Fluorescent Antibody Technique, Indirect; Humans; Mifepristone; Molecular Sequence Data; Phosphorylation; Prednisolone; Receptors, Glucocorticoid; Serine; Structure-Activity Relationship; Transcriptional Activation; Tumor Cells, Cultured | 2002 |
Fluocinolone inhibits VEGF expression via glucocorticoid receptor in human retinal pigment epithelial (ARPE-19) cells and TNF-alpha-induced angiogenesis in chick chorioallantoic membrane (CAM).
Topics: Angiogenesis Inhibitors; Animals; Cell Line; Cell Proliferation; Chick Embryo; Chorioallantoic Membrane; Enzyme-Linked Immunosorbent Assay; Epithelial Cells; Fluocinolone Acetonide; Humans; Mifepristone; Neovascularization, Physiologic; Receptors, Glucocorticoid; Retinal Pigment Epithelium; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2009 |